These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12675208)

  • 61. Pegasys (Hoffmann-La Roche).
    Barnard DL
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1530-8. PubMed ID: 11763153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa.
    Dimova RB; Talal AH
    J Hepatol; 2010 Sep; 53(3):418-20. PubMed ID: 20561707
    [No Abstract]   [Full Text] [Related]  

  • 63. [Pegylated interferon alfa-induced psoriasis].
    González-López MA; González-Vela MC; López-Escobar M; Fernando Val-Bernal J
    Med Clin (Barc); 2007 Sep; 129(9):358. PubMed ID: 17910858
    [No Abstract]   [Full Text] [Related]  

  • 64. Locally produced peginterferon as an opportunity to treat HCV in low and mid-income countries.
    Blum HE
    Arch Iran Med; 2010 Jul; 13(4):269. PubMed ID: 20597557
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of acute hepatitis C with interferon alfa-2b.
    Muir A; Rockey DC
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936122
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of acute C hepatitis in intravenous drug users.
    Bargiacchi O; Audagnotto S; Garazzino S; De Rosa FG
    J Hepatol; 2005 Jul; 43(1):186-7. PubMed ID: 15893846
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of acute hepatitis C with interferon alfa-2b.
    Seligman HK; Fox RK
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936120
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of acute hepatitis C with interferon alfa-2b.
    Tocci G; Visco-Comandini U; Antonucci G
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11936121
    [No Abstract]   [Full Text] [Related]  

  • 69. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy.
    Jabr FI; Ordinario MM
    Am J Med; 2003 Aug; 115(2):158-9. PubMed ID: 12893407
    [No Abstract]   [Full Text] [Related]  

  • 70. Editorial comment: diagnosis of acute HIV infection in hepatitis C treatment nonresponders--is extra vigilance required?
    Golia P; Talal A
    AIDS Read; 2003 Jun; 13(6):288-90. PubMed ID: 12846174
    [No Abstract]   [Full Text] [Related]  

  • 71. Movement and extrapyramidal disorders associated with interferon use in HIV/hepatitis C coinfection.
    Brito MO; Doyle T
    AIDS; 2007 Sep; 21(14):1987-9. PubMed ID: 17721114
    [No Abstract]   [Full Text] [Related]  

  • 72. [ANRS HC 02 RIBAVIC: summary and recommandations].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S104-5. PubMed ID: 19375036
    [No Abstract]   [Full Text] [Related]  

  • 73. Blurred vision: cause? Retinopathy secondary to interferon treatment.
    Bowen DW; Vyas S
    Gut; 2006 Feb; 55(2):211, 251. PubMed ID: 16407386
    [No Abstract]   [Full Text] [Related]  

  • 74. A patient with acute hepatitis C and possible IFN toxicity.
    Licata A; Di Marco V; Craxì A
    Dig Liver Dis; 2003 May; 35(5):372-3. PubMed ID: 12846412
    [No Abstract]   [Full Text] [Related]  

  • 75. Pure red cell aplasia following pegylated interferon alpha treatment.
    Arcasoy MO; Rockey DC; Heneghan MA
    Am J Med; 2004 Oct; 117(8):619-20. PubMed ID: 15465516
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of acute hepatitis C infection: more pieces of the puzzle?
    Zekry A; Patel K; McHutchison JG
    J Hepatol; 2005 Mar; 42(3):293-6. PubMed ID: 15710209
    [No Abstract]   [Full Text] [Related]  

  • 77. Acute viral hepatitis C should be treated.
    Dhiman RK; Chawla Y
    Indian J Gastroenterol; 2005; 24(2):68-71. PubMed ID: 15879654
    [No Abstract]   [Full Text] [Related]  

  • 78. Sarcoidosis after interferon therapy for chronic active hepatitis C.
    Teragawa H; Hondo T; Takahashi K; Watanabe H; Ohe H; Hattori N; Watanabe Y; Amano H; Hino F; Ohbayashi M; Urushihara T; Yonehara S
    Intern Med; 1996 Jan; 35(1):19-23. PubMed ID: 8652926
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid onset of hematotoxic effects after interferon alpha in hepatitis C.
    Dormann H; Krebs S; Muth-Selbach U; Brune K; Schuppan D; Hahn EG; Schneider HT
    J Hepatol; 2000 Jun; 32(6):1041-2. PubMed ID: 10898329
    [No Abstract]   [Full Text] [Related]  

  • 80. Peginterferon α-2a for the treatment of HIV infection.
    Asmuth DM; Utay NS; Pollard RB
    Expert Opin Investig Drugs; 2016; 25(2):249-57. PubMed ID: 26667398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.